Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  omega-3 fatty acid
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-22 of 22 for your search:
Start Over
Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 900/429/1, NCT00790140
Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 30 to 65
Sponsor: Other
Protocol IDs: 88-04-27-9683, NCT01049295
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OmegaDVS, NCT01803711
Vit D3 and Omega 3 in Chemo Induced Neuropathy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4086, NCT02294149
Dietary Intervention in Follicular Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Dietary intervention FL, NCT00455416
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 45 to 70
Sponsor: Other
Protocol IDs: STUDY00000703, NCT02101970
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Phase: Phase II
Type: Prevention
Status: Approved-not yet active
Age: 50 to 80
Sponsor: NCI, Other
Protocol IDs: 13-000432, NCI-2014-01257, P30CA016042, P50CA092131, NCT02176902
Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: A13-10-1012, NCT02333435
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: URCC13091, NCI-2014-01191, U10CA037420, UG1CA189961, R03CA175599, NCT02352779
OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer
Phase: Phase I
Type: Supportive care
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: 20130321, NCT02134600
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: OSU-13130, 1R01CA164019-01A1, NCT02295059
Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000538993, DFCI-03116, 03-116, NCT00458549
Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 35 to 75
Sponsor: Other
Protocol IDs: INAF-2010-H09-10-114, NCT01653925
Prospective Study of the Effect of Perioperative Immunonutrition on the Immune Host Defense and the Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 3-37878 L, NCT01704664
Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 30 to 55
Sponsor: Other
Protocol IDs: PSHCI 12-075, NCT01784042
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 1211, NCI-2013-00443, NCT01821833
COGNUTRIN in Breast Cancer Survivors
Phase: No phase specified
Type: Supportive care
Status: Active
Age: 45 to 75
Sponsor: Other
Protocol IDs: MCC-17089, NCT01823991
Nutrition Intervention During Chemotherapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 25 and over
Sponsor: Other
Protocol IDs: 2012-0504, NCT01871350
Impact of COX2 on Sera Biomarkers From Obese Subjects
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CTRC 13-0041, HSC20130426H, NCT02062255
Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 to 75
Sponsor: Other
Protocol IDs: AAAL2650, NCT02278965
Start Over